ArticleAmerican journal of translational research2023

The expression panel of CXCL9, GBP5, and IFNG is a potential pan-cancer biomarker to predict immunotherapy response.

Jingpu Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.